Stock ARYX ARYX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company ARYx Therapeutics, Inc.

Equities

ARYX

US0433871094

Biotechnology & Medical Research

Delayed OTC Markets
Other stock markets
 10:50:15 29/02/2024 pm IST 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for ARYx Therapeutics, Inc. -.--% -.--%

Business Summary

ARYx Therapeutics, Inc. is a United States-based pharmaceutical Company. The Company is developing a proprietary portfolio of patient-targeted, first-in-class monoclonal antibodies designed to treat seriously ill patients with difficult-to-treat diseases. It is engaged in retrometabolic drug design that focuses on the safety of oral therapies for chronic disease. The Companys clinical compounds include naronapride (ATI-7505) for gastrointestinal disorders; budiodarone (ATI-2042, for the treatment of atrial fibrillation; tecarfarin (ATI-5923) for the treatment of anticoagulation; and ATI-9242, for psychiatric disorders.

Number of employees: 56

Sales per Business

USD in Million2008Weight2009Weight Delta
Human Pharmaceutical Products
nan %
20 100.0 % 0 nan % -100.00%

Sales per region

USD in Million2008Weight2009Weight Delta
United States
nan %
20 100.0 % 0 nan % -100.00%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 33,461,975 33,461,975 ( 100.00 %) 0 100.00 %

Shareholders

NameEquities%Valuation
Lemanik Asset Management SA
0.0747 %
25,000 0.0747 % - $
AlphaStream Portfolios, Inc.
0.002630 %
880 0.002630 % - $

Company contact information

ARYx Therapeutics, Inc.

6300 Dumbarton Circle

94555, Fremont

+

address ARYx Therapeutics, Inc.(ARYX)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
ARYX THERAPEUTICS, INC. Stock ARYx Therapeutics, Inc.
-.--% 33
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+4.26% 11TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.50% 11TCr
BIONTECH SE Stock BioNTech SE
-13.10% 2.23TCr
ARGENX SE Stock argenx SE
-3.70% 2.19TCr
GENMAB A/S Stock Genmab A/S
-6.03% 1.86TCr
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-35.21% 1.81TCr
BEIGENE, LTD. Stock BeiGene, Ltd.
-10.24% 1.7TCr
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.15% 1.37TCr
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+36.96% 1.24TCr
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. ARYX Stock
  4. Company ARYx Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW